Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins

Biological Psychiatry

Volumn 52, Issue 7, 2002, Pages 708-715

  Beasley, Clare L ^a,b   Zhang, Zhi J ^a   Patten, Iain ^a   Reynolds, Gavin P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar disorder; Calbindin; Calretinin; Interneuron; Parvalbumin; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; PARVALBUMIN;

ADULT; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NERVE CELL; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CALCIUM-BINDING PROTEINS; CELL COUNT; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MIDDLE AGED; PARVALBUMINS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 0036792159     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01360-4     Document Type: Article

References (35)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:1995;258-266.
2. Akil M., Lewis D.A. Postnatal development of parvalbumin immunoreactivity in axon terminals of basket and chandelier neurons in monkey neocortex. Prog Neuropsychopharmacol Biol Psychiatry. 16:1992;329-337.
3. Bachus SE, Hyde TM, Herman MM, Eyan MF, Kleinman JE (1997): Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics. J Psychiatr Res 31:233-256.
4. Beasley C.L., Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res. 24:1997;349-355.
5. Benes F.M., Lange N. Two-dimensional versus three-dimensional cell counting A practical perspective . Trends Neurosci. 24:2001;11-17.
6. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 48:1991;996-1001.
7. Benes F.M., Todtenkopf M.S., Logiotatos P., Williams M. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J Chem Neuroanat. 20:2000;259-269.
8. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 74:1996;1021-1031.
9. Carder R., LeClerc S.L., Hendry S.H.C. Regulation of calcium-binding protein immunoreactivity in GABA neurons of macaque primary visual cortex. Cereb Cortex. 6:1996;271-287.
10. Celio M.R. Calbindin D-28K and parvalbumin in the rat nervous system. Neuroscience. 35:1990;375-475.
11. Cotter D., Landau S., Beasley C., Stevenson R., Chana G., MacMillan L., Everall I. The density and spatial distribution of GABAergic neurons in the anterior cingulate cortex in major depressive disorder, bipolar disorder and schizophrenia. Biol Psychiatry. 51:2002;377-386.
12. Danos P., Baumann B., Bernstein H.-G., Franz M., Stauch R., Northoff G.-M., et al. Schizophrenia and anteroventral thalamic nucleus Selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons . Psychiatry Res. 82:1998;1-10.
13. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia Selective increase in the density of calbindin-immunoreactive neurons . Psychiatry Res. 59:1995;81-96.
14. DeFelipe J., Hendry S.H.C., Jones E.G. Visualisation of chandelier cell axons by parvalbumin-immunoreactivity in monkey cerebral cortex. Proc Natl Acad Sci USA. 86:1989;2093-2097.
15. DeFelipe J., Jones E.G. Parvalbumin immunoreactivity reveals layer IV of monkey cerebral cortex as a mosaic of microzones of thalamic afferent terminations. Brain Res. 562:1991;39-47.
16. Demeulemeester H., Vandesande F., Orban G.A., Brando C. Heterogeneity of GABAergic cells in cat visual cortex. J Neurosci. 8:1988;988-1000.
17. Evers P., Uylings H.B. Effects of microwave pretreatment on immunocytochemical staining of vibratome sections and tissue blocks of human cerebral cortex stored in formaldehyde fixative for long periods. J Neurosci Methods. 55:1994;163-172.
18. Gabriel S.M., Davidson M., Haroutunian V., Powchik P., Bierer L.M., Purohit D.P., et al. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry. 39:1996;82-91.
19. Guidotti A., Auta J., Davis J.M., Gerevini V.D., Dwivedi Y., Grayson D.R., et al. Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder A postmortem brain study . Arch Gen Psychiatry. 57:2000;1061-1069.
20. 3H-Muscimol binding sites are increased in autopsied brains of chronic schizophrenics. Life Sci. 40:1987;259-266.
21. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques A comparison between ABC and unlabelled antibody (PAP) procedures . J Histochem Cytochem. 29:1981;577-580.
22. Jacobowitz D.M., Winsky L. Immunocytochemical localisation of calretinin in the forebrain of the rat. J Comp Neurol. 304:1991;198-218.
23. Kalus P, Senitz D, Beckmann H (1997): Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients. Psychiatry Res 75:49-59.
24. Kamphuis W., Huisman E., Wadman W.J., Lopez Da Silva F.H. Decrease in GABA immunoreactivity and alteration of GABA metabolism after kindling in the rat hippocampus. Exp Brain Res. 74:1989;375-386.
25. Lewis D.A., Lund J.S. Heterogeneity of chandelier neurons in monkey neocortex Corticotropin-releasing factor and parvalbumin-immunoreactive populations . J Comp Neurol. 293:1990;599-615.
26. Nemeroff C.B., Youngblood W.W., Manberg P.J., Prange A.J. Jr, Kizer J.S. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia. Science. 221:1983;972-975.
27. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex I. Remapping of areas 9 and 46 using quantitative criteria . Cereb Cortex. 5:1995;307-322.
28. Reynolds G.P., Beasley C.L. GABAergic neuronal subtypes in the human frontal cortex - development and deficits in schizophrenia. J Chem Neuroanat. 22:2001;95-100.
29. Somogyi P., Hodgson A.J., Smith A.D., Nunzi M.G., Gorio A., Wu J.Y. Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material. J Neurosci. 4:1984;2590-2603.
30. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophr Res. 44:2000;151-155.
31. Virgo L., Humphries C., Mortimer A., Barnes T., Hirsch S., DeBelleroche J. Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia. Biol Psychiatry. 37:1995;694-701.
32. 67 messenger RNA expression in a subset of prefrontal cortical γ-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 57:2000;237-245.
33. Woo T.U., Miller J.L., Lewis D.A. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry. 154:1997;1013-1015.
34. Woo T.U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA. 95:1998;5341-5346.
35. Zhang Z.J., Reynolds G.P. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res. 55:2002;1-10.